Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.

Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D.

Endocr Pathol. 2013 Dec;24(4):184-90. doi: 10.1007/s12022-013-9264-9.

PMID:
24037217
2.

Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.

Koo J, Mertens RB, Mirocha JM, Wang HL, Dhall D.

Mod Pathol. 2012 Jun;25(6):893-901. doi: 10.1038/modpathol.2012.34. Epub 2012 Mar 2.

3.

PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.

Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK.

Mod Pathol. 2011 Mar;24(3):412-24. doi: 10.1038/modpathol.2010.176. Epub 2010 Oct 1.

4.

Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors.

Lai JP, Mertens RB, Mirocha J, Koo J, Venturina M, Chung F, Mendez AB, Kahn M, Dhall D.

Endocr Pathol. 2015 Mar;26(1):54-62. doi: 10.1007/s12022-014-9346-3.

PMID:
25433656
5.

PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.

Long KB, Srivastava A, Hirsch MS, Hornick JL.

Am J Surg Pathol. 2010 May;34(5):723-9. doi: 10.1097/PAS.0b013e3181da0a20.

PMID:
20414099
6.

Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.

Hermann G, Konukiewitz B, Schmitt A, Perren A, Klöppel G.

Virchows Arch. 2011 Aug;459(2):147-54. doi: 10.1007/s00428-011-1118-6. Epub 2011 Jul 8.

PMID:
21739268
7.

Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.

Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y.

Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):407-14.

PMID:
18091383
8.

PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.

Chan ES, Alexander J, Swanson PE, Jain D, Yeh MM.

Am J Surg Pathol. 2012 May;36(5):737-43. doi: 10.1097/PAS.0b013e31824aba59.

PMID:
22498824
9.

Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.

Lorenzo PI, Jimenez Moreno CM, Delgado I, Cobo-Vuilleumier N, Meier R, Gomez-Izquierdo L, Berney T, Garcia-Carbonero R, Rojas A, Gauthier BR.

Histochem Cell Biol. 2011 Nov;136(5):595-607. doi: 10.1007/s00418-011-0866-3. Epub 2011 Sep 20.

10.
11.

[The diagnostic value of plasma chromogranin A in neuroendocrine tumors].

Yang XO, Li JN, Qian JM, Yang H, Chen Q, Lu L.

Zhonghua Nei Ke Za Zhi. 2011 Feb;50(2):124-7. Chinese.

PMID:
21418832
12.
13.

PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.

Jernman J, Kallio P, Hagström J, Välimäki MJ, Haapasalo H, Alitalo K, Arola J, Haglund C.

Virchows Arch. 2015 Sep;467(3):279-84. doi: 10.1007/s00428-015-1795-7. Epub 2015 Jun 11.

PMID:
26063416
14.

Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.

Weissferdt A, Tang X, Wistuba II, Moran CA.

Mod Pathol. 2013 Dec;26(12):1554-60. doi: 10.1038/modpathol.2013.111. Epub 2013 Jun 21.

15.
16.

Cdx2 as a marker for neuroendocrine tumors of unknown primary sites.

Erickson LA, Papouchado B, Dimashkieh H, Zhang S, Nakamura N, Lloyd RV.

Endocr Pathol. 2004 Fall;15(3):247-52.

PMID:
15640551
17.

The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal.

Liau JY, Tsai JH, Jeng YM, Kuo KT, Huang HY, Liang CW, Yang CY.

Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):57-63. doi: 10.1097/PAI.0000000000000149.

PMID:
25710581
18.

[Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].

Yao W, Wang W, Li G.

Zhonghua Zhong Liu Za Zhi. 2014 Apr;36(4):287-93. Chinese.

PMID:
24989916
19.

Cyclin A predicts metastatic potential of rectal neuroendocrine tumors.

Jernman J, Välimäki MJ, Hagström J, Louhimo J, Haapasalo H, Arola J, Haglund C.

Hum Pathol. 2014 Aug;45(8):1605-9. doi: 10.1016/j.humpath.2014.03.012. Epub 2014 Apr 13.

PMID:
24824027
Items per page

Supplemental Content

Write to the Help Desk